TrialScientific reports2015

Randomized, Multicenter Study of Gefitinib Dose-escalation in Advanced Non-small-cell Lung Cancer Patients Achieved Stable Disease after One-month Gefitinib Treatment.

Cong Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.